Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients
Authors:
Open Access
- 10 February 2017
- journal article
- research article
- Published by SAGE Publications in Diabetes & Vascular Disease Research
- Vol. 14 (2) , 116-121
Abstract
Background: Musclin is a newly identified skeletal muscle–derived secretory factor, which has been recently characterized as a stimulator that induces insulin resistance in mice. However, the pathophysiological role of musclin in humans remains poorly understood. The aim of this study was to explore the potential correlations between musclin plasma levels and various metabolic parameters in patients with type 2 diabetes mellitus. Materials and methods: In this hospital-based study, plasma samples were collected from the enrolled individuals, including 38 newly diagnosed, treatment-naive type 2 diabetes mellitus patients and 41 age- and gender-matched control subjects. Plasma musclin levels were examined by radioimmunoassay. Results: Compared with the control group, musclin plasma levels were significantly higher in untreated type 2 diabetes mellitus patients. Musclin levels in the plasma of newly diagnosed type 2 diabetes mellitus patients were positively correlated with fasting plasma glucose, haemoglobin A1c, serum insulin, triglycerides and homeostasis model assessment of insulin resistance. Furthermore, multivariate logistic regression analysis showed that the level of musclin was associated with the presence of type 2 diabetes mellitus. Receiver operating characteristic curve analysis yielded an area under the curve for musclin of 0.718 in type 2 diabetes mellitus. Conclusion: The circulating concentration of musclin was significantly increased in type 2 diabetes mellitus patients. Our results suggest that musclin has a strong relationship with insulin resistance in type 2 diabetes mellitus.Keywords
This publication has 17 references indexed in Scilit:
- Type 2 diabetes across generations: from pathophysiology to prevention and managementThe Lancet, 2011
- Edward F. Adolph Distinguished Lecture: Muscle as an endocrine organ: IL-6 and other myokinesJournal of Applied Physiology, 2009
- Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinaseDiabetologia, 2009
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes, 2009
- Oversecretion of interleukin-15 from skeletal muscle reduces adiposityAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6Physiological Reviews, 2008
- Role of myokines in exercise and metabolismJournal of Applied Physiology, 2007
- Pathogenesis of type 2 diabetes mellitusMedical Clinics of North America, 2004
- Musclin, a Novel Skeletal Muscle-derived Secretory FactorJournal of Biological Chemistry, 2004
- The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDMDiabetes, 1988